Loading...

Strategic and Regulatory Consulting

Strategy and development consulting, regulatory affairs and Japan market research/feasibility
Learn More

Non-Clinical CRO Solutions

Bioanalysis, CMC and GMP Analytical Testing, Safety Pharmacology, Toxicology and Efficacy Studies
Learn More

Clinical CRO Solutions

Clinical development from Phase I to Phase IV clinical studies
Learn More

Site Management Solutions

Study coordinator, site administrator and patient recruitment
Learn More

CDMO Solutions

Preformulation study, formulation & process development, investigational product manufacturing and commercial supply
Learn More

Sales and Marketing

Sales team establishment, sales staff dispatch and remote communication support
Learn More

Patient Support Services

Call center and drug adherence support program
Learn More

Healthcare Digital Platforms

PHR for prescription drug, vaccination and symptoms
Learn More

Consumer Health Solutions (Japan Only)

Self test kits, healthcare portal and local government support
Learn More

Japan Market Entry

Full pharmaceutical capablities for overseas business partners to enter into the Japan Market
Learn More

Asia Clinical Trials

Supporting our client’s clinical trials throughout the Asia Pacific region in more than 13 countries
Learn More

Orphan Drug

Regulatory affairs, supply chain management, quality assurance, pharmacovigilance, sales and marketing
Learn More

Oncology Drug Development

Strategic development planning, clinical trials, manufacturing and commercialization
Learn More

Cell and Gene Therapy

Regulatory consulting, nonclinical and clinical studies and post-marketing
Learn More

Medical Devices & IVD

Consulting on regulatory affairs for the latest medical devices and in vitro diagnostics (IVD)
Learn More

Your Trusted Service Partner for the US, Japan and Asia

Click to view our global locations, filters by location and/or service.

Explore our Services by Geographical Location

Resources

  • [Roundtable] Innovating At The Intersection Of Non-Clinical And Clinical: Addressing Bioanalytical Challenges For Complex Therapies

    White Papers

Notice regarding Designation as an Orphan Drug and Supplemental New Drug Application for Sodium Phenylbutyrate

  • Notice regarding Designation as an Orphan Drug and Supplemental New Drug Application for Sodium Phenylbutyrate

    News and Events

Our Tailored Pharmaceutical Solutions

CMIC, Japan’s first and largest Contract Research Organization, offers tailored solutions for pharmaceutical companies, medical device manufacturers, academia, bio-ventures and medical institutions. Using our collective strengths, we offer a broad range of services from preclinical research to practical applications.